Pahl Pharmaceutical Professionals, LLC

Oklahoma City, Oklahoma 73112

2 studies enrolling now · 8 studies all time

What they study most

Attention Deficit Hyperactivity Disorder, Cannabis Withdrawal, Insomnia, Major Depressive Disorder, Moderate to Severe Opioid-use Disorder, Opioid Use Disorder

Studies at this site

• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder — Recruiting now
• An Open-Label Study of Azetukalner in Major Depressive Disorder — Enrolling by invitation
• Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users — Completed
• Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder — Completed
• SUBLOCADE Long-term Outcomes — Completed
• Effect of PP-01 on Cannabis Withdrawal Syndrome — Completed
• Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia — Completed
• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia — Completed